Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

This publication has 28 references indexed in Scilit:

• HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
  The Lancet Oncology, 2009
• HPV Screening for Cervical Cancer in Rural India
  New England Journal of Medicine, 2009
• Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis
  BMJ, 2008
• Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial
  The Lancet Oncology, 2008
• Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
  Vaccine, 2008
• Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test
  JNCI Journal of the National Cancer Institute, 2008
• Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer
  New England Journal of Medicine, 2007
• Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
  The Lancet, 2007
• Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial
  JNCI Journal of the National Cancer Institute, 2006
• Overview of the European and North American studies on HPV testing in primary cervical cancer screening
  International Journal of Cancer, 2006